Knight Therapeutics, Inc.

Knight Therapeutics, Inc.

11.73
CAD
-0.19
(-1.59%)
0.16EPS
65.28P/E
1.04BMarket Cap
Mar 25Next Earn

Knight Therapeutics, Inc. Documents

Q3 FY2024 · Management discussion and analysis

November 7, 2024 · 48 pages

Read Knight Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this management discussion and analysis
Create a free account to start reading

Full documents are included with Professional

Q3 FY2024 documents